All Posts

The year 2025 marked an important milestone  for the InnovPrecMed project, as partners from across Europe joined forces to strengthen innovation capacity in the field of Precision Medicine . The project brought together universities, research institutes, and industry partners with a shared ambition to support innovation, entrepreneurship, and collaboration in healthcare technologies. InnovPrecMed aims to bridge the gap between science, business, and innovation . Through train

The InnovPrecMed project  is pleased to announce a new partnership with the NanoPrecMed Consortium , aimed at strengthening collaboration and knowledge exchange in the rapidly evolving field of precision medicine and nanomedicine . This partnership reflects more than just a shared vision – it represents a shared mission to support innovation, interdisciplinary collaboration, and the translation of scientific discoveries into real-world healthcare solutions . As part of this c

The InnovPrecMed project was recently showcased at IGLO Open in Brussels , an event organised by CZELO under the theme “Union of Skills.”  The meeting brought together representatives of European universities, research organisations, and innovation stakeholders to discuss future skills needs and the role of higher education institutions in strengthening Europe’s innovation capacity. InnovPrecMed was represented by Project Lead Andrew David Miller  from Mendel University in Br

Last week, the InnovPrecMed team participated in the IVAP 2025 Workshop in Kraków, an important event bringing together higher education institutions, project consortia, and innovation stakeholders from across Europe. The workshop, organised within the framework of the EIT HEI Initiative, served as a dynamic platform for sharing knowledge, building partnerships, and exploring new approaches to strengthening innovation capacity in academia. On behalf of InnovPrecMed, Project L

As part of ongoing activities within the InnovPrecMed project, a team from Mendel University in Brno carried out a series of institutional visits to three consortium partners: Fachhochschule Oberösterreich (Linz) , Ludwig Boltzmann Institute for Nanovesicular Precision Medicine (Salzburg)  and Biology Centre of the Czech Academy of Sciences (České Budějovice) . The purpose of these visits was to deepen cooperation within the consortium, discuss key project objectives, and exp

Rockfish Bio, a spin-off emerging from research at LBI Trauma, BOKU University and the Medical University of Vienna, has won two prestigious awards this season: the Science & Business Award 2025 from the Rudolf Sallinger Fund and the BOKU Start-up Award for Healthy Aging. Co-founded by LBI Trauma director and InnovPrecMed member Johannes Grillari and Ingo Lämmermann, Rockfish Bio is developing a new class of senolytic drug candidates that selectively eliminate senescent cells